chr3-57110230-T-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_017563.5(IL17RD):āc.392A>Cā(p.Lys131Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00115 in 1,607,560 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.00070 ( 1 hom., cov: 33)
Exomes š: 0.0012 ( 7 hom. )
Consequence
IL17RD
NM_017563.5 missense
NM_017563.5 missense
Scores
1
8
10
Clinical Significance
Conservation
PhyloP100: 5.73
Genes affected
IL17RD (HGNC:17616): (interleukin 17 receptor D) This gene encodes a membrane protein belonging to the interleukin-17 receptor (IL-17R) protein family. The encoded protein is a component of the interleukin-17 receptor signaling complex, and the interaction between this protein and IL-17R does not require the interleukin. The gene product also affects fibroblast growth factor signaling, inhibiting or stimulating growth through MAPK/ERK signaling. Alternate splicing generates multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.07136911).
BS2
High AC in GnomAd4 at 107 AD,Digenic gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL17RD | NM_017563.5 | c.392A>C | p.Lys131Thr | missense_variant | 4/13 | ENST00000296318.12 | NP_060033.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL17RD | ENST00000296318.12 | c.392A>C | p.Lys131Thr | missense_variant | 4/13 | 1 | NM_017563.5 | ENSP00000296318.7 |
Frequencies
GnomAD3 genomes AF: 0.000703 AC: 107AN: 152248Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
107
AN:
152248
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000893 AC: 214AN: 239576Hom.: 0 AF XY: 0.00105 AC XY: 136AN XY: 129460
GnomAD3 exomes
AF:
AC:
214
AN:
239576
Hom.:
AF XY:
AC XY:
136
AN XY:
129460
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00119 AC: 1735AN: 1455194Hom.: 7 Cov.: 31 AF XY: 0.00126 AC XY: 913AN XY: 723010
GnomAD4 exome
AF:
AC:
1735
AN:
1455194
Hom.:
Cov.:
31
AF XY:
AC XY:
913
AN XY:
723010
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000702 AC: 107AN: 152366Hom.: 1 Cov.: 33 AF XY: 0.000698 AC XY: 52AN XY: 74512
GnomAD4 genome
AF:
AC:
107
AN:
152366
Hom.:
Cov.:
33
AF XY:
AC XY:
52
AN XY:
74512
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
4
ALSPAC
AF:
AC:
9
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
6
ExAC
AF:
AC:
113
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 28, 2024 | Variant summary: IL17RD c.392A>C (p.Lys131Thr) results in a non-conservative amino acid change located in the Interleukin 17 receptor D, N-terminal (IPR031951) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0011 in 1607560 control chromosomes in the gnomAD database (v4.0.0), including 8 homozygotes. This frequency does not allow conclusion about variant significance. c.392A>C has been reported in the literature in individuals affected with Kallman syndrome (Miraoui_2013). These reports do not provide unequivocal conclusions about association of the variant with Hypogonadotropic Hypogonadism 18 With Or Without Anosmia. At least one publication reports experimental evidence evaluating an impact on protein function indicating it alters protein function (Miraoui_2013). The following publication have been ascertained in the context of this evaluation (PMID: 23643382). ClinVar contains an entry for this variant (Variation ID: 50867). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 05, 2018 | - - |
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 07, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 24, 2023 | Observed in the heterozygous state in two individuals with Kallman syndrome and an individual with self-limited delayed puberty, as well as in one control sample, in the published literature (Miraoui et al., 2013; Zhu et al., 2015); Published functional studies show that the K131T variant disrupts normal protein function (Miraoui et al., 2013); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23643382, 25636053, 34426522) - |
Delayed puberty Pathogenic:1
Likely pathogenic, criteria provided, single submitter | case-control | Chan Lab, Boston Children's Hospital | Nov 01, 2014 | - - |
Hypogonadotropic hypogonadism 18 with anosmia Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 02, 2013 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at